CASE REPORT article
Front. Oncol.
Sec. Thoracic Oncology
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1635424
This article is part of the Research TopicEmerging Trends in Cancer Research: Diagnostic and Therapeutic BreakthroughsView all 12 articles
Pitfalls in Anatomic Pathology and Clinical Oncology: A Case of Misdiagnosed Pulmonary Ewing Sarcoma as SCLC
Provisionally accepted- 1University of Balamand, Beirut, Lebanon
- 2Mount Lebanon Hospital, Beirut, Lebanon
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
In oncology, an accurate pathological diagnosis can often mean the difference between cure and failure, potentially leading to a patient's demise. In the case we are presenting a 28-year-old never smoking gentleman, the initial diagnosis of small cell lung cancer was questionable yet confirmed by the anatomic pathology laboratory upon reevaluation. This ultimately led to therapeutic failure following an initial complete remission and likely contributed to the failure of salvage therapy once the diagnosis was corrected to pulmonary Ewing sarcoma. Primary pulmonary Ewing sarcoma is a rare malignancy that is often overlooked in adults. This case underscores not only the striking clinical and histopathological overlap between SCLC and pulmonary Ewing sarcoma, but also the potentially fatal consequences of missing key diagnostic red flags – including the patient's young age, non-smoking status and atypical clinical course. Through this patient's journey we emphasize the importance of multidisciplinary collaboration, the limitations of relying solely on immunohistochemistry and the critical role of early molecular testing. This case serves as a stark reminder that behind every pathology report is a human life, one that depends on vigilance, humility, and thoroughness of the medical team entrusted with their care.
Keywords: Lung malignancy, pulmonary Ewing sarcoma, Immunohistochemistry, molecular testing, Multidisciplinary team, Misdiagnosis
Received: 25 Jun 2025; Accepted: 21 Oct 2025.
Copyright: © 2025 El Waary, Chami, Houcheimy, Zrein, Akl and Kamar. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Jawad K Zrein, jawad.zrein@gmail.com
Francois G Kamar, francois@kamarclinic.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.